Regulation and function of serine kinase networks in lymphocytes

Current Opinion in Immunology

Volumn 15, Issue 3, 2003, Pages 294-298

  Cantrell, Doreen A ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIACYLGLYCEROL; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN SERINE KINASE; PROTEIN SERINE THREONINE KINASE;

ENZYME ACTIVATION; ENZYME REGULATION; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION;

EID: 0037716820     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(03)00052-9     Document Type: Review

References (46)

1. Acuto O., Cantrell D. T cell activation and the cytoskeleton. Annu. Rev. Immunol. 18:2000;165-184.
2. Koretzky G.A., Myung P.S. Positive and negative regulation of T-cell activation by adaptor proteins. Nature Rev. Immunol. 1:2001;95-107.
3. Teruel M.N., Meyer T. Translocation and reversible localization of signaling proteins: a dynamic future for signal transduction. Cell. 103:2000;181-184.
4. Lafont V., Astoul E., Laurence A., Liautard J., Cantrell D. The T cell antigen receptor activates phosphatidylinositol 3-kinase-regulated serine kinases protein kinase B and ribosomal S6 kinase 1. FEBS Lett. 486:2000;38-42.
5. Matthews S.A., Rozengurt E., Cantrell D. Characterization of serine 916 as an in vivo autophosphorylation site for protein kinase D/Protein kinase Cmu. J. Biol. Chem. 274:1999;26543-26549.
6. Rincon M. MAP-kinase signaling pathways in T cells. Curr. Opin. Immunol. 13:2001;339-345.
7. Cantrell D.A. Transgenic analysis of thymocyte signal transduction. Nat. Rev. Immunol. 2:2002;20-27.
8. Cantrell D.A. Phosphoinositide 3-kinase signalling pathways. J. Cell Sci. 114:2001;1439-1445.
9. ••].
10. 3 accumulation: one in the T cell-APC contact zone and the other at the opposite, antipodal pole of the cell. This bipolar localisation of a key signalling molecule reveals that the immunological synapse is not the sole site of either immediate or sustained signal transduction in activated T cells.
11. Astoul E., Watton S., Cantrell D. The dynamics of protein kinase B regulation during B cell antigen receptor engagement. J. Cell Biol. 145:1999;1511-1520.
12. Lee K.H., Holdorf A.D., Dustin M.L., Chan A.C., Allen P.M., Shaw A.S. T cell receptor signaling precedes immunological synapse formation. Science. 295:2002;1539-1542.
13. Ward S.G., Cantrell D.A. Phosphoinositide 3-kinases in T lymphocyte activation. Curr. Opin. Immunol. 13:2001;332-338.
14. Fruman D.A., Snapper S.B., Yballe C.M., Davidson L., Yu J.Y., Alt F.W., Cantley L.C. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85 alpha. Science. 283:1999;393-397.
15. Li Z., Jiang H., Xie W., Zhang Z., Smrcka A.V., Wu D. Roles of PLC-beta2 and -beta3 and PI3Kγ in chemoattractant-mediated signal transduction. Science. 287:2000;1046-1049.
16. ••].
17. ••] describe the T- and B-cell defects in mice that lack p110δ.
18. Cantrell D. Protein kinase B (Akt) regulation and function in T lymphocytes. Semin. Immunol. 14:2002;19-26.
19. Brennan P., Babbage J.W., Burgering B.M., Groner B., Reif K., Cantrell D.A. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity. 7:1997;679-689.
20. Brennan P., Babbage J.W., Thomas G., Cantrell D. p70(s6k) integrates phosphatidylinositol 3-kinase and rapamycin-regulated signals for E2F regulation in T lymphocytes. Mol. Cell Biol. 19:1999;4729-4738.
21. Astoul E, Laurence AD, Totty N, Beer S, Alexander DR, Cantrell DA: Approaches to define antigen receptor induced serine kinase signal transduction pathways. J Biol Chem 2003 (published online 5January 2003) DOI: 10.1074/jbc.M211252200.
22. ••].
23. ••].
24. ••], which shows that inhibition of PI3K prevents T cells increasing in cell size in response to antigen-receptor engagement).
25. Plas DR, Thompson CB: Akt activation promotes degradation of tuberin and FOXO3a via the proteasome. J Biol Chem 2003.
26. Kops G.J., Medema R.H., Glassford J., Essers M.A., Dijkers P.F., Coffer P.J., Lam E.W., Burgering B.M. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol. Cell Biol. 22:2002;2025-2036.
27. Stahl M., Dijkers P.F., Kops G.J., Lens S.M., Coffer P.J., Burgering B.M., Medema R.H. The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J. Immunol. 168:2002;5024-5031.
28. Parekh D.B., Ziegler W., Parker P.J. Multiple pathways control protein kinase C phosphorylation. EMBO J. 19:2000;496-503.
29. Su T.T., Guo B., Kawakami Y., Sommer K., Chae K., Humphries L.A., Kato R.M., Kang S., Patrone L., Wall R.et al. PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. Nat. Immunol. 3:2002;780-786.
30. Miyamoto A., Nakayama K., Imaki H., Hirose S., Jiang Y., Abe M., Tsukiyama T., Nagahama H., Ohno S., Hatakeyama S.et al. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cδ Nature. 416:2002;865-869.
31. ••].
32. ••] the importance of PKCδ for the immune system is shown by the phenotype of PKCδ KO mice, which develop autoimmunity and fail to develop normal B-cell tolerance.
33. Sun Z., Arendt C.W., Ellmeier W., Schaeffer E.M., Sunshine M.J., Gandhi L., Annes J., Petrzilka D., Kupfer A., Schwartzberg P.L.et al. PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature. 404:2000;402-407.
34. Freiberg B.A., Kupfer H., Maslanik W., Delli J., Kappler J., Zaller D.M., Kupfer A. Staging and resetting T cell activation in SMACs. Nat. Immunol. 3:2002;911-917.
35. Monks C.R., Kupfer H., Tamir I., Barlow A., Kupfer A. Selective modulation of protein kinase C-theta during T-cell activation. Nature. 385:1997;83-86.
36. Monks C.R., Freiberg B.A., Kupfer H., Sciaky N., Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature. 395:1998;82-86.
37. Matthews S., Rozengurt E., Cantrell D. Characterisation of Serine 916 as an in vivo autophosphorylation site for PKD/PKCm. J. Biol. Chem. 274:1999;26543-26549.
38. Matthews S.A., Iglesias T., Rozengurt E., Cantrell D. Spatial and temporal regulation of protein kinase D (PKD). EMBO J. 19:2000;2935-2945.
39. Matthews S.A., Dayalu R., Thompson L.J., Scharenberg A.M. Regulation of PKCnu by the B cell antigen receptor. J. Biol. Chem. 278:2003;9086-9091 This paper, together with [41], identifies PKDs as antigen-receptor serine kinases and downstream targets for PKC in lymphocytes. The authors establish that PKD is active in two intracellular localisations: PKD is initially active at the plasma membrane, but during the sustained response to antigen-receptor engagement, PKD is active in the cytosol.
40. VanLint J., Rykx A., Maeda Y., Vantus T., Sturany S., Malhotra V., Vandenheede J.R., Seufferlein T. Protein kinase D: an intracellular traffic regulator on the move. Trends Cell Biol. 12:2002;193-200.
41. Matthews S.A., Rozengurt E., Cantrell D. Protein kinase D. A selective target for antigen receptors and a downstream target for protein kinase C in lymphocytes. J. Exp. Med. 191:2000;2075-2082.
42. Waldron RT, Rozengurt E: Protein kinase C phosphorylates protein kinase D activation loop Ser744 and Ser748 and releases autoinhibition by the PH domain. J Biol Chem 2002.
43. Waldron R.T., Rey O., Iglesias T., Tugal T., Cantrell D., Rozengurt E. Activation loop Ser744 and Ser748 in protein kinase D are transphosphorylated in vivo. J. Biol. Chem. 276:2001;32606-32615.
44. ••].
45. Kane S., Sano H., Liu S.C., Asara J.M., Lane W.S., Garner C.C., Lienhard G.E. A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. J. Biol. Chem. 277:2002;22115-22118.
46. ••] show how antibodies reactive with phosphorylated PKB and PKC substrate sequences have been used in combination with computer-based searches of kinase databases to define new sites of serine phosphorylation in intact cells.